BIOMAT Database Logo BIOMAT Database Logo

Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. 1982

L M Milstone, and J McGuire, and R C Ablow

A boy with epidermolytic hyperkeratosis was treated systemically for 4 1/2 years with 13-cis-retinoic acid. At the age of 10 1/2 years, he developed pain in his right knee and radiographic evidence of partial closure of the proximal epiphysis of the right tibia. Similar radiographic changes have been described in individuals ingesting excessive amounts of vitamin A.

UI MeSH Term Description Entries
D007642 Keratosis Any horny growth such as a wart or callus. Keratoderma Blennorrhagicum,Keratoma,Keratosis Blennorrhagica,Blennorrhagica, Keratosis,Blennorrhagicas, Keratosis,Blennorrhagicum, Keratoderma,Blennorrhagicums, Keratoderma,Keratoderma Blennorrhagicums,Keratomas,Keratoses,Keratosis Blennorrhagicas
D008297 Male Males
D001847 Bone Diseases Diseases of BONES. Bone Disease,Disease, Bone,Diseases, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004838 Epiphyses The head of a long bone that is separated from the shaft by the epiphyseal plate until bone growth stops. At that time, the plate disappears and the head and shaft are united. Epiphysis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013977 Tibia The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally. Tibias
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid
D015474 Isotretinoin A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects. 13-cis-Retinoic Acid,Accutane,Isotretinoin Zinc Salt, 13-cis-Isomer,Ro 4-3780,Roaccutane,13 cis Retinoic Acid,Isotretinoin Zinc Salt, 13 cis Isomer,Ro 4 3780,Ro 43780

Related Publications

L M Milstone, and J McGuire, and R C Ablow
Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma.
November 2016, Pediatric blood & cancer,
L M Milstone, and J McGuire, and R C Ablow
Oral 9-cis-retinoic acid versus 13-cis-retinoic acid in acne therapy.
January 1996, Dermatology (Basel, Switzerland),
L M Milstone, and J McGuire, and R C Ablow
Oral 13-cis-retinoic acid in severe acne.
October 1979, The Medical journal of Australia,
L M Milstone, and J McGuire, and R C Ablow
Isotretinoin (13-cis-retinoic acid)-associated premature ventricular contractions.
January 2009, The Turkish journal of pediatrics,
L M Milstone, and J McGuire, and R C Ablow
[Rosacea. Oral therapy with 13-cis retinoic acid].
December 1980, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
L M Milstone, and J McGuire, and R C Ablow
Oral 13-cis retinoic acid is superior to 9-cis retinoic acid in sebosuppression in human beings.
March 1996, Journal of the American Academy of Dermatology,
L M Milstone, and J McGuire, and R C Ablow
Treatment of keratoacanthomas with oral 13-cis-retinoic acid.
September 1980, The New England journal of medicine,
L M Milstone, and J McGuire, and R C Ablow
[Oral treatment of rosacea with 13-cis-retinoic acid].
November 1981, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
L M Milstone, and J McGuire, and R C Ablow
Premature Epiphyseal Closure of the Lower Extremities Contributing to Short Stature after cis-Retinoic Acid Therapy in Medulloblastoma: A Case Report.
January 2016, Hormone research in paediatrics,
L M Milstone, and J McGuire, and R C Ablow
13-cis-retinoic acid in the treatment of oral leukoplakia.
December 1986, The New England journal of medicine,
Copied contents to your clipboard!